Parkinson’s disease (PD) is a degenerative neurological condition primarily affecting middle-aged and older adults and is characterized by tremors, muscular rigidity, and slow, clumsy movement. It is connected to the brain’s basal ganglia atrophy and a lack of the neurotransmitter dopamine. Levodopa is considered a linchpin despite the availability of other agents for reducing the symptoms of Parkinson’s disease. However, prolonged levodopa usage can lead to levodopa-induced dyskinesia (LID).
As per a study by Jose (2000), Parkinson’s disease is an age-related neurodegenerative disorder with an average onset age of 60. In the United States, approximately 1 million ...
